These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

235 related articles for article (PubMed ID: 20534593)

  • 1. Over-expression of ST3Gal-I promotes mammary tumorigenesis.
    Picco G; Julien S; Brockhausen I; Beatson R; Antonopoulos A; Haslam S; Mandel U; Dell A; Pinder S; Taylor-Papadimitriou J; Burchell J
    Glycobiology; 2010 Oct; 20(10):1241-50. PubMed ID: 20534593
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An alpha2,3 sialyltransferase (ST3Gal I) is elevated in primary breast carcinomas.
    Burchell J; Poulsom R; Hanby A; Whitehouse C; Cooper L; Clausen H; Miles D; Taylor-Papadimitriou J
    Glycobiology; 1999 Dec; 9(12):1307-11. PubMed ID: 10561455
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MUC1 in human and murine mammary carcinoma cells decreases the expression of core 2 β1,6-N-acetylglucosaminyltransferase and β-galactoside α2,3-sialyltransferase.
    Solatycka A; Owczarek T; Piller F; Piller V; Pula B; Wojciech L; Podhorska-Okolow M; Dziegiel P; Ugorski M
    Glycobiology; 2012 Aug; 22(8):1042-54. PubMed ID: 22534569
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cyclooxygenase-2 enzyme induces the expression of the α-2,3-sialyltransferase-3 (ST3Gal-I) in breast cancer.
    Sproviero D; Julien S; Burford B; Taylor-Papadimitriou J; Burchell JM
    J Biol Chem; 2012 Dec; 287(53):44490-7. PubMed ID: 23275522
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sialylated core 1 based O-linked glycans enhance the growth rate of mammary carcinoma cells in MUC1 transgenic mice.
    Mungul A; Cooper L; Brockhausen I; Ryder K; Mandel U; Clausen H; Rughetti A; Miles DW; Taylor-Papadimitriou J; Burchell JM
    Int J Oncol; 2004 Oct; 25(4):937-43. PubMed ID: 15375543
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Overexpression of sialyltransferase CMP-sialic acid:Galbeta1,3GalNAc-R alpha6-Sialyltransferase is related to poor patient survival in human colorectal carcinomas.
    Schneider F; Kemmner W; Haensch W; Franke G; Gretschel S; Karsten U; Schlag PM
    Cancer Res; 2001 Jun; 61(11):4605-11. PubMed ID: 11389097
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mouse ST6Gal sialyltransferase gene expression during mammary gland lactation.
    Dalziel M; Huang RY; Dall'Olio F; Morris JR; Taylor-Papadimitriou J; Lau JT
    Glycobiology; 2001 May; 11(5):407-12. PubMed ID: 11425801
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Increased alpha2,6 sialylation of N-glycans in a transgenic mouse model of hepatocellular carcinoma.
    Pousset D; Piller V; Bureaud N; Monsigny M; Piller F
    Cancer Res; 1997 Oct; 57(19):4249-56. PubMed ID: 9331085
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The evolution of galactose alpha2,3-sialyltransferase: Ciona intestinalis ST3GAL I/II and Takifugu rubripes ST3GAL II sialylate Galbeta1,3GalNAc structures on glycoproteins but not glycolipids.
    Lehmann F; Kelm S; Dietz F; von Itzstein M; Tiralongo J
    Glycoconj J; 2008 May; 25(4):323-34. PubMed ID: 17973185
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genetically altered mice with different sialyltransferase deficiencies show tissue-specific alterations in sialylation and sialic acid 9-O-acetylation.
    Martin LT; Marth JD; Varki A; Varki NM
    J Biol Chem; 2002 Sep; 277(36):32930-8. PubMed ID: 12068010
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reversible sialylation: synthesis of cytidine 5'-monophospho-N-acetylneuraminic acid from cytidine 5'-monophosphate with alpha2,3-sialyl O-glycan-, glycolipid-, and macromolecule-based donors yields diverse sialylated products.
    Chandrasekaran EV; Xue J; Xia J; Locke RD; Matta KL; Neelamegham S
    Biochemistry; 2008 Jan; 47(1):320-30. PubMed ID: 18067323
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A transfected sialyltransferase that is elevated in breast cancer and localizes to the medial/trans-Golgi apparatus inhibits the development of core-2-based O-glycans.
    Whitehouse C; Burchell J; Gschmeissner S; Brockhausen I; Lloyd KO; Taylor-Papadimitriou J
    J Cell Biol; 1997 Jun; 137(6):1229-41. PubMed ID: 9182658
    [TBL] [Abstract][Full Text] [Related]  

  • 13. α2,3-Sialyltransferase ST3Gal IV promotes migration and metastasis in pancreatic adenocarcinoma cells and tends to be highly expressed in pancreatic adenocarcinoma tissues.
    Pérez-Garay M; Arteta B; Llop E; Cobler L; Pagès L; Ortiz R; Ferri MJ; de Bolós C; Figueras J; de Llorens R; Vidal-Vanaclocha F; Peracaula R
    Int J Biochem Cell Biol; 2013 Aug; 45(8):1748-57. PubMed ID: 23726834
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cell surface n-acetylneuraminic acid alpha2,3-galactoside-dependent intercellular adhesion of human colon cancer cells.
    Dimitroff CJ; Pera P; Dall'Olio F; Matta KL; Chandrasekaran EV; Lau JT; Bernacki RJ
    Biochem Biophys Res Commun; 1999 Mar; 256(3):631-6. PubMed ID: 10080950
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The relative activities of the C2GnT1 and ST3Gal-I glycosyltransferases determine O-glycan structure and expression of a tumor-associated epitope on MUC1.
    Dalziel M; Whitehouse C; McFarlane I; Brockhausen I; Gschmeissner S; Schwientek T; Clausen H; Burchell JM; Taylor-Papadimitriou J
    J Biol Chem; 2001 Apr; 276(14):11007-15. PubMed ID: 11118434
    [TBL] [Abstract][Full Text] [Related]  

  • 16. alpha 2-6-Linked sialic acids on N-glycans modulate carcinoma differentiation in vivo.
    Hedlund M; Ng E; Varki A; Varki NM
    Cancer Res; 2008 Jan; 68(2):388-94. PubMed ID: 18199532
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Loss of amphiregulin reduces myoepithelial cell coverage of mammary ducts and alters breast tumor growth.
    Mao SPH; Park M; Cabrera RM; Christin JR; Karagiannis GS; Oktay MH; Zaiss DMW; Abrams SI; Guo W; Condeelis JS; Kenny PA; Segall JE
    Breast Cancer Res; 2018 Oct; 20(1):131. PubMed ID: 30367629
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Liver membrane proteome glycosylation changes in mice bearing an extra-hepatic tumor.
    Lee A; Chick JM; Kolarich D; Haynes PA; Robertson GR; Tsoli M; Jankova L; Clarke SJ; Packer NH; Baker MS
    Mol Cell Proteomics; 2011 Sep; 10(9):M900538MCP200. PubMed ID: 20167946
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterization of cancer associated mucin type O-glycans using the exchange sialylation properties of mammalian sialyltransferase ST3Gal-II.
    Chandrasekaran EV; Xue J; Xia J; Locke RD; Patil SA; Neelamegham S; Matta KL
    J Proteome Res; 2012 Apr; 11(4):2609-18. PubMed ID: 22329400
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mammalian sialyltransferase ST3Gal-II: its exchange sialylation catalytic properties allow labeling of sialyl residues in mucin-type sialylated glycoproteins and specific gangliosides.
    Chandrasekaran EV; Xue J; Xia J; Locke RD; Patil SA; Neelamegham S; Matta KL
    Biochemistry; 2011 Nov; 50(44):9475-87. PubMed ID: 21913655
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.